About Healthcare Professionals Patients News Join Us Investor Relations Contact Us
CN EN

News

Explore our latest news
22 Feb,2024
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE

Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Health and P...

more
29 Jan,2024
Zylox-Tonbridge’s ZYLOX Venous Stent System Receives NMPA Marketing Approval

On January 22nd, Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZYLOX Peripheral Venous St...

more
04 Jan,2024
Zylox-Tonbridge’s ZYLOX® Phoenix Peripheral Detachable Fibered Coil Embolization System Receives NMPA Marketing Approval

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZYLOX® Phoenix Peripheral Detachable Fiber...

more
21 Dec,2023
Zylox-Tonbridge Completed Patient Enrollment for ZENFLEX® Peripheral Stent System Clinical Trial in the EU

December 18, 2023. Zylox-Tonbridge (2190. HK, "the Company"), a leading vascular interventional medical device manufacturer in China, announced the completion of the total enrollment of 100 ...

more
06 Dec,2023
The 2023 Investor Open Day of Zylox-Tonbridge was successfully held

On November 29th, the 2023 Investor Open Day of Zylox-Tonbridge ("2190. HK", hereinafter referred to as "the Company") was successfully held in Hangzhou, China. The event attracted...

more
18 Sep,2023
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series

Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total-Cap...

more
Zylox-Tonbridge Medical